Private Wealth Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History
Private Wealth Asset Management, LLC
- $754 Billion
- Q2 2025
A detailed history of Private Wealth Asset Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Private Wealth Asset Management, LLC holds 87 shares of BMRN stock, worth $4,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 87
-0.0%
Holding current value
$4,758
Previous $6.15 Million
22.24%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
677Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.04 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$863 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$826 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$672 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...